扶正消瘤汤治疗消化道恶性肿瘤化疗患者的临床研究

目的:分析扶正消瘤汤治疗消化道恶性肿瘤化疗患者的临床效果。方法:将我院2017年7月-2018年12月收治的60例消化道恶性肿瘤患者作为研究对象,采用数字随机法将患者分成两组,一组采用常规化疗,为对照组,一组在此基础上联合扶正消瘤汤治疗,为研究组,对比两组患者的治疗效果。结果:研究组患者的有效率为96.67%(29/30),高于对照组的73.33%(22/30),两组数据对比差异存在统计学意义(P<0.05);研究组患者治疗后CD4^+/CD8^+为(1.45±0.11),其数据与治疗前和治疗后比较差异有统计学意义(P<0.05);研究组患者不良反应发生率为10%(3/30),与对照组的20%(6/30)比较差异无统计学意义(P>0.05)。结论:扶正消瘤汤治疗消化道恶性肿瘤患者疗效显著,可以有效控制病情进展,提高患者免疫力,且不会增加不良反应,安全性较高,建议在临床中进行推广。

A clinical study on treating malignant digestive tumor withthe Fuzheng Xiaoliu decoction plus chemotherapy

Objective:To analyze the clinical effect of the Fuzheng Xiaoliu decoction(扶正消瘤汤)plus chemotherapy on digestive tract malignancies.Methods:60 patients were divided into two groups by digital randomization.The control group was treated by conventional chemotherapy.The research group was given the Fuzheng Xiaoliu decoction more.Results:The efficiency in the research group was 96.67%(29/30),was higher than 73.33%(22/30)in the control group(P﹤0.05).CD4+/CD8+was(1.45±0.11)in the study group,with a statistically significant difference between before and after treatment(P﹤0.05).The incidence of adverse reactions in the study group was 10%(3/30),and 20%(6/30)in the control group(P﹥0.05).Conclusion:The Fuzheng Xiaoliu decoction is effective on digestive tract malignancies,by effectively controlling the progress of the disease,improving the immunity,with fewer adverse reaction,safety,and is worthy of promotion in the clinic.